Single Pass Albumin Dialysis in Patients With Cirrhosis (DACAR)

Assistance Publique - Hôpitaux de Paris

Status and phase

Completed

Phase 2

Phase 1

Conditions

Acute on Chronic Hepatic Failure

Encephalopathy

Cirrhosis

Hepatorenal Syndrome

Treatments

Device: Single pass albumin dialysis

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT00764049

P050902

Details and patient eligibility

About

The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

Full description

Albumin dialysis has beneficial effects in patients with acute on chronic liver failure. However, current devices are complex and costly. The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

Enrollment

11 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Minimum age of 18 years
Written consent after information of the patient or, in case of inability, by a parent or a close if he is present.
Patient having a cirrhosis researched by previous exams (liver biopsy) or, in the absence of previous diagnosis, diagnosed in view of the results of clinical, biological and morphological data, whatever the origin of the cirrhosis (virus of hepatitis B, virus of hepatitis C, extreme consumption of alcohol or other reasons)

Exclusion criteria

Participation to an other study in the 4 weeks before
Active digestive bleeding, unchecked by the pharmacological treatments and the endoscopic techniques.